Revenio Group Corporation’s Financial statement release 2024 will be published on Thursday, February 13, 2025, approximately at 09.00 a.m. (EET). A live webcast and teleconference call for analysts, investors, and media will be held in English at 3.30 p.m. (EET) on the same day. Register to the event below.

Financial statement release 2024

## Welcome to Revenio's investor website

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.



![](https://storage.googleapis.com/ir-pages-assets-fi/Revenio/elise-zimmerman-ndpRohZL6bE-unsplash.jpg)

### Outlook and guidance

See our guidance

Key figures

<h2 style="color:white" color:"white">Popular links</h2>

![](https://inderes-ir-pages-prod-assets.storage.googleapis.com/reveniogroup/images/Robin%20Pulkkinen%20Cropped-optimized.jpg)

### Investor contacts

CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi

Thank you for your answers. We will do our best to develop our operations on the basis of this feedback.

Financial statement release 2024

Welcome to Revenio's investor website

Outlook and guidance

Upcoming events

Key figures

{{stockPrice}} EUR

{{stockPricePercentageChange}}

{{stockPriceLatestDate}}

96.6

MEUR

2023

27.3

%

2023

Releases

Latest video

Popular links

Investor contacts